Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Access to effective antimicrobials: a worldwide challenge.
Laxminarayan R, Matsoso P, Pant S, Brower C, Røttingen JA, Klugman K, Davies S. Laxminarayan R, et al. Among authors: rottingen ja. Lancet. 2016 Jan 9;387(10014):168-75. doi: 10.1016/S0140-6736(15)00474-2. Epub 2015 Nov 18. Lancet. 2016. PMID: 26603918 Review.
Introduction and geographic availability of new antibiotics approved between 1999 and 2014.
Kållberg C, Årdal C, Salvesen Blix H, Klein E, M Martinez E, Lindbæk M, Outterson K, Røttingen JA, Laxminarayan R. Kållberg C, et al. Among authors: rottingen ja. PLoS One. 2018 Oct 16;13(10):e0205166. doi: 10.1371/journal.pone.0205166. eCollection 2018. PLoS One. 2018. PMID: 30325963 Free PMC article.
Allocating external financing for health: a discrete choice experiment of stakeholder preferences.
Grépin KA, Pinkstaff CB, Hole AR, Henderson K, Norheim OF, Røttingen JA, Ottersen T. Grépin KA, et al. Among authors: rottingen ja. Health Policy Plan. 2018 Feb 1;33(suppl_1):i24-i30. doi: 10.1093/heapol/czx017. Health Policy Plan. 2018. PMID: 29415237 Free PMC article.
Towards a coherent global framework for health financing: recommendations and recent developments.
Ottersen T, Elovainio R, Evans DB, McCoy D, Mcintyre D, Meheus F, Moon S, Ooms G, Røttingen JA. Ottersen T, et al. Among authors: rottingen ja. Health Econ Policy Law. 2017 Apr;12(2):285-296. doi: 10.1017/S1744133116000505. Health Econ Policy Law. 2017. PMID: 28332466
Global public goods for health: weaknesses and opportunities in the global health system.
Moon S, Røttingen JA, Frenk J. Moon S, et al. Among authors: rottingen ja. Health Econ Policy Law. 2017 Apr;12(2):195-205. doi: 10.1017/S1744133116000451. Health Econ Policy Law. 2017. PMID: 28332461
UN High-Level Meeting on antimicrobials--what do we need?
Laxminarayan R, Amábile-Cuevas CF, Cars O, Evans T, Heymann DL, Hoffman S, Holmes A, Mendelson M, Sridhar D, Woolhouse M, Røttingen JA. Laxminarayan R, et al. Among authors: rottingen ja. Lancet. 2016 Jul 16;388(10041):218-20. doi: 10.1016/S0140-6736(16)31079-0. Lancet. 2016. PMID: 27479554 No abstract available.
Pull Incentives for Antibacterial Drug Development: An Analysis by the Transatlantic Task Force on Antimicrobial Resistance.
Årdal C, Røttingen JA, Opalska A, Van Hengel AJ, Larsen J. Årdal C, et al. Among authors: rottingen ja. Clin Infect Dis. 2017 Oct 15;65(8):1378-1382. doi: 10.1093/cid/cix526. Clin Infect Dis. 2017. PMID: 29017240
Antimicrobial resistance: The complex challenge of measurement to inform policy and the public.
Wernli D, Jørgensen PS, Harbarth S, Carroll SP, Laxminarayan R, Levrat N, Røttingen JA, Pittet D. Wernli D, et al. Among authors: rottingen ja. PLoS Med. 2017 Aug 17;14(8):e1002378. doi: 10.1371/journal.pmed.1002378. eCollection 2017 Aug. PLoS Med. 2017. PMID: 28817562 Free PMC article.
An antibiotic's journey from marketing authorization to use, Norway.
Årdal C, Blix HS, Plahte J, Røttingen JA. Årdal C, et al. Among authors: rottingen ja. Bull World Health Organ. 2017 Mar 1;95(3):220-226. doi: 10.2471/BLT.16.172874. Epub 2017 Jan 19. Bull World Health Organ. 2017. PMID: 28250535 Free PMC article.
Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance.
Sciarretta K, Røttingen JA, Opalska A, Van Hengel AJ, Larsen J. Sciarretta K, et al. Among authors: rottingen ja. Clin Infect Dis. 2016 Dec 1;63(11):1470-1474. doi: 10.1093/cid/ciw593. Epub 2016 Aug 30. Clin Infect Dis. 2016. PMID: 27578820 Review.
177 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback